Clinical Trials Logo

Clinical Trial Summary

The aim of this study is the comparison of oxygen delivery during OLV+capnothorax and OLV+capnothorax and CPAP.


Clinical Trial Description

One-lung ventilation (OLV) is utilized mainly during thoracic procedures when surgeon needs the lung deflated to expose the surgical field. In this situation both lungs are perfused but only one is ventilated resulting in high grade of shunt and eventually hypoxemia .

Most of thoracic procedures are performed with the pt lying on one side; the deflated lung receive less blood flow both for the gravity and for the hypoxic pulmonary vasoconstriction (HPV) thus reducing the shunt.

If the pt lyes supine, as in VATS atrial fibrillation (AF) surgical ablation, the protective effect of gravity is lost, shunt remains high and severe hypoxemia is common. Some algorithms are used to improve oxygenation during OLV: high fraction of inspired oxygen (FiO2), positive end expiratory pressure (PEEP) on the ventilated lung, continuous positive airway pressure (CPAP) on the deflated lung, but the latter can be used with caution during VATS because of the obstruction of the surgical field. Increasing the pressure in the pleural cavity with carbon dioxyde (CO2) (capnothorax) could decrease the blood flow in the deflated lung, helping in reducing shunt but this is not yet demonstrated and this manouver could decrease cardiac output. The oxygen delivery (DO2) is cardiac output (CO) by oxygen content and during this surgery both these factors could be compromised.

All consecutive pts electively subjected to OLV in supine position for VATS ablation of AF will be enrolled. On the day of surgery pts will be randomly allocated in two groups depending on the management of the non-ventilated lung (capnothorax or capnothorax and CPAP.

Pts in supine position; tracheal intubation with left-sided double lumen tube (DLT) and position confirmed by bronchoscopy. Lungs are initially ventilated with pressure controlled mode (PCV) at a tidal volume (TV) of 7 mL/kg, I:E ratio 1:2, respiratory rate (RR) to obtain a PaCO2 40-45 mmHg, FiO2 =1 and PEEP 5 cm H2O. During OLV inspiratory pressure is reduced to obtain a TV of 5 mL/Kg, maintaining FiO2=1, PEEP 5 cm H2O and adjusting RR to obtain a PaCO2 40-45 mmHg. Capnothorax is obtained by the insufflation of CO2 and maintained at a preset pressure of 10 mmHg. CPAP on the non ventilated lung is set at 10 cm H2O and FiO2=1.

After institution of OLV pts will be randomized to receive capnothorax alone (Group CA) or to receive capnothorax and CPAP (Group CC)

Arterial and central venous blood gasanalyses, hemodynamic and respiratory variables will be recorded at the following points:

a) spontaneous breathing at FiO2=0.21; b) 10' after double lung ventilation (TLV); c) 10'after OLV; d) 10' after OLV and capnothorax (Group CA) or OLV, capnothorax and CPAP (Group CC) e) double lung ventilation (TLV) at the end of the surgical procedure Differences of DO2, shunt fraction (QS/QT), and derived variables between the two groups will be tested by T-test.

40 pts (20 per groups) will allow 80% power to deem as significant (alpha = 0.05) a difference of 50 mL/min in DO2 (with standard deviation of 50 mL/min) between the two managements of the non-ventilated lung.

If SaO2 will decrease below 90% an alveolar recruitment strategy will be performed and if not effective TLV will be initiated together with dropping the pt out of the study ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02959515
Study type Interventional
Source Centro Cardiologico Monzino
Contact luca salvi, MD
Phone +39 02 58002
Email LUCA.SALVI@CCFM.IT
Status Recruiting
Phase N/A
Start date October 2016
Completion date April 2018

See also
  Status Clinical Trial Phase
Completed NCT03508050 - Clamping the Double Lumen Tube N/A
Completed NCT02919267 - Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms N/A
Not yet recruiting NCT03649386 - Heated Circuit for One-lung Ventilation N/A
Completed NCT02981537 - Two-staged Approach in Positioning Endobronchial Blockers Without Fiberoptic Guidance N/A
Completed NCT03503565 - Intraoperative Neuromuscular Blockade and Postoperative Atelectasis
Completed NCT03296449 - Comparison Between CPAP and HFJV During One-lung Ventilation in VATS N/A
Recruiting NCT04725318 - Esophageal Pressure Measurements During One-lung Ventilation
Completed NCT02137291 - IPg2 Study: Left-sided Lung Isolation N/A
Completed NCT00486616 - Examination of Double-Lumen Tube Placement by Functional Electrical Impedance Tomography N/A
Completed NCT04260451 - Driving Pressure and Postoperative Pulmonary Complications in Thoracic Surgery N/A
Completed NCT05050552 - Oxygen Reserve Index in One-Lung Ventilation During Elective Thoracic Operations
Completed NCT04760262 - The Effect of Anesthesia on Cerebral Oxygenation
Recruiting NCT05907525 - Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation N/A
Unknown status NCT01171560 - Evaluation of the EZ Blocker Phase 4
Completed NCT05946707 - Effects of Oxygen Supply After Lung Isolation in Thoracic Surgery N/A
Completed NCT03234621 - Protective Ventilation Strategy N/A
Completed NCT04740151 - Individualized PEEP in Thoracic Surgery N/A
Not yet recruiting NCT06210256 - Compared Unidirectional Valve Apparatus and Occluding the Non-ventilated Endobronchial Lumen for Lung Collapse. N/A
Active, not recruiting NCT02963025 - Protective Ventilation With High Versus Low PEEP During One-lung Ventilation for Thoracic Surgery N/A
Completed NCT02912598 - Lung Isolation in Thoracic Surgery - a Randomized Trial Comparing the VivaSightâ„¢ EB Endobronchial Blocker With Established Devices Phase 4